Trial
NCT00538343
RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Brain Metastases
Intervention
berubicin hydrochloride (RTA 744)
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29